Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection.
Influenza vaccines that target the highly variable surface glycoproteins hemagglutinin and neuraminidase cause inconvenience of having vaccination every year. For this reason, development of universal vaccines targeting conserved viral components is needed. In this study, we generated recombinant ad...
Main Authors: | So-Hee Kim, Joo Young Kim, Youngjoo Choi, Huan H Nguyen, Man Ki Song, Jun Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3783479?pdf=render |
Similar Items
-
Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
by: So-Hee Kim, et al.
Published: (2013-01-01) -
Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection.
by: So-Hee Kim, et al.
Published: (2013-01-01) -
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
by: Patrick Tjok Joe, et al.
Published: (2019-07-01) -
Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
by: Shim Byoung-Shik, et al.
Published: (2012-09-01) -
Cloning and Expression of Recombinant Nucleoprotein of Influenza H1N1
by: Somaie Tavakoli, et al.
Published: (2015-04-01)